key: cord-0913373-xm7fa9vu
authors: Hogardt, M.; Besier, S.; Vorbeck, L.; Göttig, S.; Wichelhaus, T.; Villinger, D.; Hack, D.; Sommer, J.; Ilievski, V.; Kempf, V.A.J.
title: Management of bacteriological specimens of patients suffering from coronavirus disease 2019 (COVID-19)
date: 2020-10-24
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.10.022
sha: fb5e67e41075efcb199ca0a8430c6b9e709c89a8
doc_id: 913373
cord_uid: xm7fa9vu

nan

In this context, we reviewed the potential infection risk (reflected by the viral load) by 92 type of specimen according to the current knowledge (Table 1) . Further, we 93 evaluated the spectrum of microbiological samples of the first 100 patients, which 94 were hospitalized at the University hospital Frankfurt due to confirmed or highly Frequently, respiratory samples were submitted to the laboratory (n=205; 17%).

Of note, the available reports on the SARS-CoV-2 positivity and the viral load for Table 2 . The correct labeling of specimens from COVID-19 patients is of particular importance 145 in order to guide these specimens in the appropriate workflow. Our experience is that It has to be realized that an outbreak scenario in a diagnostic laboratory leads to 193 severe constraints in a hospital´s diagnostic capacity as described recently (29) 4 2 safety level can be adjusted to standard safety precautions if robust data on the source specific risk (see table 1 ) is available (see Table 1 ).

# if available on site / ensuring room separation of high-risk sample procession and the reduction of laboratory staff to a minimum (laboratory coat, hand 6 disinfection, decontamination of work surfaces included). 

Oropharyngeal swab 100% (n=1)

Anal/rectal swab 22% (n=9)

Plasma 15% (n=41, plasma)

30% (n=10, severe disease)

Saliva (oropharyngeal) 50% (n=8, severe disease)

[28] of positive samples (total number of tested samples), reference. 3 2 mean cycle value threshold value of 30